Chemoinformaics analysis of 2-HYDROXY-2-PHENYLACETAMIDE
| Molecular Weight | 151.165 | nRot | 2 |
| Heavy Atom Molecular Weight | 142.093 | nRig | 7 |
| Exact Molecular Weight | 151.063 | nRing | 1 |
| Solubility: LogS | -1.272 | nHRing | 0 |
| Solubility: LogP | 0.155 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 22.0651 |
| nHD | 2 | BPOL | 9.32686 |
| QED | 0.634 |
| Synth | 2.21 |
| Natural Product Likeliness | 0.015 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.942 |
| HIA | 0.039 |
| CACO-2 | -5.081 |
| MDCK | 0.000319988 |
| BBB | 0.993 |
| PPB | 0.257491 |
| VDSS | 0.836 |
| FU | 0.676421 |
| CYP1A2-inh | 0.078 |
| CYP1A2-sub | 0.103 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.274 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.217 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.284 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.221 |
| CL | 2.897 |
| T12 | 0.379 |
| hERG | 0.028 |
| Ames | 0.017 |
| ROA | 0.013 |
| SkinSen | 0.174 |
| Carcinogencity | 0.015 |
| EI | 0.478 |
| Respiratory | 0.028 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.878355 |